Toponomics analysis of drug-induced changes in arachidonic acid-dependent signaling pathways during spinal nociceptive processing.
暂无分享,去创建一个
Gerd Geisslinger | Dieter Steinhilber | D. Steinhilber | K. Scholich | G. Geisslinger | T. Maier | Sandra Pierre | Klaus Scholich | Carlo Angioni | C. Angioni | Bona Linke | Ovidiu Coste | Wiebke Becker | Thorsten Jürgen Maier | Claus Wittpoth | B. Linke | S. Pierre | C. Wittpoth | O. Coste | Wiebke Becker
[1] R. Botting,et al. Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Levine,et al. Contribution of 5- and 12-lipoxygenase products to mechanical hyperalgesia induced by prostaglandin E2 and epinephrine in the rat , 2003, Experimental Brain Research.
[3] Min-Xia Wang,et al. Expression and regulation of peroxiredoxin 5 in human osteoarthritis , 2002, FEBS letters.
[4] E. E. Bagley,et al. Cellular Actions Of Opioids And Other Analgesics: Implications For Synergism In Pain Relief , 2000, Clinical and experimental pharmacology & physiology.
[5] Xudong Huang,et al. Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology , 2004, Annals of the New York Academy of Sciences.
[6] K. Scholich,et al. Is mPGES-1 a promising target for pain therapy? , 2006, Trends in pharmacological sciences.
[7] S. Karpatkin,et al. Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase. , 2007, Blood.
[8] W. Schubert,et al. Analyzing proteome topology and function by automated multidimensional fluorescence microscopy , 2006, Nature Biotechnology.
[9] K. Scholich,et al. Toponomics Analysis of Functional Interactions of the Ubiquitin Ligase PAM (Protein Associated with Myc) during Spinal Nociceptive Processing*S , 2008, Molecular & Cellular Proteomics.
[10] M. Michaelis,et al. Inhibition of Cyclooxygenases by Dipyrone , 2007, British journal of pharmacology.
[11] E. Puré,et al. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis , 2006, Proceedings of the National Academy of Sciences.
[12] R. Sittl,et al. The Effects on Platelet Aggregation and Prostanoid Biosynthesis of two Parenteral Analgesics: Ketorolac Tromethamine and Dipyrone , 1996, Thrombosis and Haemostasis.
[13] Charles N. Serhan,et al. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.
[14] L. Audoly,et al. Redirection of Eicosanoid Metabolism in mPGES-1-deficient Macrophages* , 2005, Journal of Biological Chemistry.
[15] H. Huang,et al. Regulation of cyclooxygenase and 12-lipoxygenase catalysis by phospholipid hydroperoxide glutathione peroxidase in A431 cells. , 2000, Prostaglandins, leukotrienes, and essential fatty acids.
[16] Katherine B Percarpio,et al. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. , 2006, Chemistry & biology.
[17] C. Serhan,et al. Resolvins and protectins in the termination program of acute inflammation. , 2007, Trends in immunology.
[18] C. Brenneis,et al. Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient mice , 2007, Journal of cellular and molecular medicine.
[19] F. Gago,et al. Regulation of cyclooxygenase activity by metamizol. , 1999, European journal of pharmacology.
[20] B. Giusti,et al. Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone. , 1990, Prostaglandins, leukotrienes, and essential fatty acids.
[21] B. Uretsky,et al. Phosphorylation of 5-Lipoxygenase at Ser523 by Protein Kinase A Determines Whether Pioglitazone and Atorvastatin Induce Proinflammatory Leukotriene B4 or Anti-Inflammatory 15-Epi-Lipoxin A4 Production , 2008, The Journal of Immunology.
[22] O. Werz,et al. 5-Lipoxygenase: regulation of expression and enzyme activity. , 2007, Trends in biochemical sciences.
[23] L. Philipsen,et al. Ulcerative Colitis Response Profiles in Crohn's Disease and Mucosa Reveals Distinctive Immune Proteomic Analysis of the Inflamed Intestinal , 2007 .
[24] G. Geisslinger,et al. Cerebrospinal fluid prostaglandins after systemic dipyrone intake , 1998, Clinical pharmacology and therapy.
[25] O. Werz,et al. Selenium-dependent peroxidases suppress 5-lipoxygenase activity in B-lymphocytes and immature myeloid cells. The presence of peroxidase-insensitive 5-lipoxygenase activity in differentiated myeloid cells. , 1996, European journal of biochemistry.
[26] F. Hofmann,et al. Cysteine-Rich Protein 2, a Novel Downstream Effector of cGMP/cGMP-Dependent Protein Kinase I-Mediated Persistent Inflammatory Pain , 2008, The Journal of Neuroscience.
[27] Walter Schubert,et al. Fluorescence detection of protein clusters in individual cells and tissue sections by using toponome imaging system: sample preparation and measuring procedures , 2007, Nature Protocols.
[28] K. Honn,et al. 12-Lipoxygenase in Lewis lung carcinoma cells: molecular identity, intracellular distribution of activity and protein, and Ca(2+)-dependent translocation from cytosol to membranes. , 1995, Prostaglandins.
[29] L. Philipsen,et al. Systematic high-content proteomic analysis reveals substantial immunologic changes in colorectal cancer. , 2008, Cancer research.
[30] B. Bonnekoh,et al. Topo-Proteomic in situ Analysis of Psoriatic Plaque under Efalizumab Treatment , 2007, Skin Pharmacology and Physiology.
[31] P. Jakobsson,et al. Inhibition of prostaglandin E2 synthesis by SC‐560 is independent of cyclooxygenase 1 inhibition , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] V. Gutierrez,et al. The analgesic effect of crotoxin on neuropathic pain is mediated by central muscarinic receptors and 5-lipoxygenase-derived mediators , 2008, Pharmacology Biochemistry and Behavior.
[33] D. Steinhilber,et al. Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Imlay,et al. Pathways of oxidative damage. , 2003, Annual review of microbiology.
[35] A. Ottani,et al. Dual acting anti-inflammatory drugs. , 2007, Current topics in medicinal chemistry.
[36] O. Werz,et al. Phosphorylation‐ and stimulus‐dependent inhibition of cellular 5‐lipoxygenase activity by nonredox‐type inhibitors , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] H. Seyberth,et al. Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. , 1999, Journal of the American Society of Nephrology : JASN.
[38] J. Lindgren,et al. 15-Lipoxygenation of leukotriene A(4). Studies Of 12- and 15-lipoxygenase efficiency to catalyze lipoxin formation. , 2000, Biochimica et biophysica acta.
[39] M. Romano. Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins. , 2006, Inflammation & allergy drug targets.